IL171993A0 - Carboxylic acid compound and medicine containing the same - Google Patents

Carboxylic acid compound and medicine containing the same

Info

Publication number
IL171993A0
IL171993A0 IL171993A IL17199305A IL171993A0 IL 171993 A0 IL171993 A0 IL 171993A0 IL 171993 A IL171993 A IL 171993A IL 17199305 A IL17199305 A IL 17199305A IL 171993 A0 IL171993 A0 IL 171993A0
Authority
IL
Israel
Prior art keywords
same
carboxylic acid
acid compound
medicine containing
diabetes
Prior art date
Application number
IL171993A
Other languages
English (en)
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of IL171993A0 publication Critical patent/IL171993A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL171993A 2003-05-23 2005-11-16 Carboxylic acid compound and medicine containing the same IL171993A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47273703P 2003-05-23 2003-05-23
JP2003154372 2003-05-30
PCT/JP2004/007316 WO2004103946A1 (fr) 2003-05-23 2004-05-21 Compose d'acide carboxylique et medicament contenant ce compose

Publications (1)

Publication Number Publication Date
IL171993A0 true IL171993A0 (en) 2009-02-11

Family

ID=33479004

Family Applications (1)

Application Number Title Priority Date Filing Date
IL171993A IL171993A0 (en) 2003-05-23 2005-11-16 Carboxylic acid compound and medicine containing the same

Country Status (14)

Country Link
EP (1) EP1627866B1 (fr)
KR (1) KR20060031605A (fr)
AT (1) ATE418532T1 (fr)
AU (1) AU2004241224A1 (fr)
BR (1) BRPI0411136A (fr)
CA (1) CA2526637A1 (fr)
DE (1) DE602004018634D1 (fr)
EA (1) EA010020B1 (fr)
IL (1) IL171993A0 (fr)
MX (1) MXPA05012612A (fr)
MY (1) MY132415A (fr)
NO (1) NO20056135L (fr)
NZ (1) NZ544155A (fr)
WO (1) WO2004103946A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080045567A1 (en) * 2004-06-01 2008-02-21 Kowa Co., Ltd Therapeutic Agent for Hyperlipemia and Therapeutic Agent for Diabetes
WO2006118187A1 (fr) * 2005-04-28 2006-11-09 Ube Industries, Ltd. Procédé servant à produire un sel de type 2,2-dichloro-12-(4-halophényl)dodécanate et procédé servant à produire un intermédiaire de production de celui-ci
EP2003112A1 (fr) 2006-03-31 2008-12-17 Kowa Company, Ltd. Procede de production de compose acide carboxylique
WO2009038204A1 (fr) * 2007-09-17 2009-03-26 Pharma Frontier Co., Ltd. Nouveau composé dérivé d'un acide gras à longue chaîne et agoniste des récepteurs couplés aux protéines g qui contient le composé en tant qu'ingrédient actif

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
PL373035A1 (en) * 2002-01-16 2005-08-08 Kowa Company, Ltd. Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid

Also Published As

Publication number Publication date
MY132415A (en) 2007-10-31
EP1627866A4 (fr) 2006-10-04
MXPA05012612A (es) 2006-02-22
AU2004241224A1 (en) 2004-12-02
NO20056135L (no) 2005-12-22
BRPI0411136A (pt) 2006-07-18
EP1627866B1 (fr) 2008-12-24
DE602004018634D1 (de) 2009-02-05
ATE418532T1 (de) 2009-01-15
KR20060031605A (ko) 2006-04-12
NZ544155A (en) 2008-03-28
CA2526637A1 (fr) 2004-12-02
EA010020B1 (ru) 2008-06-30
WO2004103946A1 (fr) 2004-12-02
EP1627866A1 (fr) 2006-02-22
EA200501853A1 (ru) 2006-06-30

Similar Documents

Publication Publication Date Title
IL148384A0 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
HK1089749A1 (en) Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract
IL166748A0 (en) Pyrazole derivative medicinal composition containing the same medicinal use thereof and intermediatefor production thereof
WO2004022529A3 (fr) Derives de diaryluree et leur utilisation comme bloqueurs de canaux chlorure
EP1092435A4 (fr) Medicaments antidiabetiques
IL171993A0 (en) Carboxylic acid compound and medicine containing the same
HK1054373A1 (en) Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
EP1147772A4 (fr) Compositions medicamenteuses utilisees dans le traitement de la fibrillation auriculaire
AU6487094A (en) 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
TW200740786A (en) Novel cercosporamide derivatives
TW200503681A (en) Carboxylic compound and medicine comprising the same
LV11030A (lv) Morfolinolsavienojums ta iegusana un pielietosana
EP1156057A4 (fr) Derives de malto-oligosaccharide et leurs utilisations
CA2016985A1 (fr) Derives de dehydrocholecalciferol
HUP0303353A2 (hu) Profilaktikus és terápiás szer diabeteses komplikációkhoz
EP1666472A4 (fr) Derive d'acide phenylacetique, ainsi que procede de production et utilisation de celui-ci
AU2001260695A1 (en) Malto-oligosaccharide derivatives and use thereof
TH71668A (th) สารประกอบคาร์บอกซิลิก และสารที่ใช้รักษาโรคซึ่งประกอบด้วยสารประกอบนี้
CA2489834A1 (fr) Derives de l'acide benzoique ortho-substitues destines au traitement de l'insulinoresistance
EP1484316A4 (fr) Nouveau derive de l'acide propionique
WO2003063858A3 (fr) Derives de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires
EP1589023A4 (fr) Derives d'oligosaccharide
AU1287892A (en) Method of inhibiting the progressive development of diabetes mellitus
ATE186907T1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung